Details for New Drug Application (NDA): 213218
✉ Email this page to a colleague
The generic ingredient in SOAANZ is torsemide. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the torsemide profile page.
Summary for 213218
Tradename: | SOAANZ |
Applicant: | Sarfe Pharms |
Ingredient: | torsemide |
Patents: | 1 |
Pharmacology for NDA: 213218
Physiological Effect | Increased Diuresis at Loop of Henle |
Suppliers and Packaging for NDA: 213218
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SOAANZ | torsemide | TABLET;ORAL | 213218 | NDA | Sarfez Pharmaceuticals Inc | 73502-286 | 73502-286-15 | 5 BLISTER PACK in 1 CARTON (73502-286-15) / 6 TABLET, FILM COATED in 1 BLISTER PACK (73502-286-09) |
SOAANZ | torsemide | TABLET;ORAL | 213218 | NDA | Sarfez Pharmaceuticals Inc | 73502-287 | 73502-287-16 | 5 BLISTER PACK in 1 CARTON (73502-287-16) / 6 TABLET, FILM COATED in 1 BLISTER PACK (73502-287-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Jun 14, 2021 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 6, 2033 | Product Flag? | Y | Substance Flag? | Delist Request? |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
Approval Date: | Jun 14, 2021 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 6, 2033 | Product Flag? | Y | Substance Flag? | Delist Request? |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Nov 17, 2021 | TE: | RLD: | Yes |
Complete Access Available with Subscription